Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7XCZ

Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7054 and BA7125 fab (local refinement)

7XCZ の概要
エントリーDOI10.2210/pdb7xcz/pdb
EMDBエントリー33130
分子名称Spike glycoprotein, BA7054 fab, BA7125 fab, ... (5 entities in total)
機能のキーワードviral protein
由来する生物種Severe acute respiratory syndrome coronavirus 2
詳細
タンパク質・核酸の鎖数5
化学式量合計115824.17
構造登録者
Liu, Z.,Liu, S. (登録日: 2022-03-26, 公開日: 2023-03-01, 最終更新日: 2025-06-18)
主引用文献Wang, Y.,Yan, A.,Song, D.,Dong, C.,Rao, M.,Gao, Y.,Qi, R.,Ma, X.,Wang, Q.,Xu, H.,Liu, H.,Han, J.,Duan, M.,Liu, S.,Yu, X.,Zong, M.,Feng, J.,Jiao, J.,Zhang, H.,Li, M.,Yu, B.,Wang, Y.,Meng, F.,Ni, X.,Li, Y.,Shen, Z.,Sun, B.,Shao, X.,Zhao, H.,Zhao, Y.,Li, R.,Zhang, Y.,Du, G.,Lu, J.,You, C.,Jiang, H.,Zhang, L.,Wang, L.,Dou, C.,Liu, Z.,Zhao, J.
Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.
Cell Discov, 9:3-3, 2023
Cited by
PubMed Abstract: SARS-CoV-2 Omicron subvariants have demonstrated extensive evasion from monoclonal antibodies (mAbs) developed for clinical use, which raises an urgent need to develop new broad-spectrum mAbs. Here, we report the isolation and analysis of two anti-RBD neutralizing antibodies BA7208 and BA7125 from mice engineered to produce human antibodies. While BA7125 showed broadly neutralizing activity against all variants except the Omicron sublineages, BA7208 was potently neutralizing against all tested SARS-CoV-2 variants (including Omicron BA.1-BA.5) except Mu. By combining BA7208 and BA7125 through the knobs-into-holes technology, we generated a biparatopic antibody BA7208/7125 that was able to neutralize all tested circulating SARS-CoV-2 variants. Cryo-electron microscopy structure of these broad-spectrum antibodies in complex with trimeric Delta and Omicron spike indicated that the contact residues are highly conserved and had minimal interactions with mutational residues in RBD of current variants. In addition, we showed that administration of BA7208/7125 via the intraperitoneal, intranasal, or aerosol inhalation route showed potent therapeutic efficacy against Omicron BA.1 and BA.2 in hACE2-transgenic and wild-type mice and, separately, effective prophylaxis. BA7208/7125 thus has the potential to be an effective candidate as an intervention against COVID-19.
PubMed: 36609558
DOI: 10.1038/s41421-022-00509-9
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (3.2 Å)
構造検証レポート
Validation report summary of 7xcz
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon